• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MUA
Click for more information
0.00% 80.0¢

MITULA GROUP LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MUA
Ann: Removal from the Official List - Close of trade today 		12/02/19 1 487
12/02/19 Last post  aussiemillion Comments Created with Sketch.  1  Views Created with Sketch.  487 
MUA
Ann: Ceasing to be a substantial holder 		18/01/19 0 186
18/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  186 
MUA
Ann: Implementation of Scheme 		15/01/19 6 1.2K
15/01/19 Last post  david Comments Created with Sketch.  6  Views Created with Sketch.  1.2K 
MUA
Ann: Final Director's Interest Notice (x5) 		11/01/19 0 105
11/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  105 
MUA
Ann: Initial Director's Interest Notice (x6) 		11/01/19 0 95
11/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  95 
MUA
News: MUA Lifull Says It Has Acquired All Outstanding Shares Of Mitula 		09/01/19 0 208
09/01/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  208 
MUA
Ann: MUA announces record revenue and share buy-back program
2
02/01/19 85 19K
02/01/19 Last post  Jausty1919 Comments Created with Sketch.  85  Views Created with Sketch.  19K 
MUA
Ann: Change in substantial holding 		17/12/18 1 456
17/12/18 Last post  Jukebox45 Comments Created with Sketch.  1  Views Created with Sketch.  456 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.